ResMed, Inc. (RMD) Reports In-Line Q4 EPS
ResMed, Inc. (NYSE: RMD) reported Q4 EPS of $0.62 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
